Neoadjuvant therapy in locally advanced esophageal squamous cell carcinoma / 中华胃肠外科杂志
Chinese Journal of Gastrointestinal Surgery
; (12): 312-318, 2023.
Article
en Zh
| WPRIM
| ID: wpr-986791
Biblioteca responsable:
WPRO
ABSTRACT
The efficacy of surgery alone for locally advanced esophageal squamous cell carcinoma (ESCC) is limited. In-depth studies concerning combined therapy for ESCC have been carried out worldwide, especially the neoadjuvant treatment model, including neoadjuvant chemotherapy (nCT), neoadjuvant chemoradiotherapy (nCRT), neoadjuvant chemotherapy combined with immunotherapy (nICT), neoadjuvant chemoradiotherapy combined with immunotherapy (nICRT), etc. With the advent of the immunity era, nICT and nICRT have attracted much attention from researchers. An attempt was thus made to take an overview of the evidence-based research advance regarding the neoadjuvant therapy of ESCC.
Texto completo:
1
Índice:
WPRIM
Asunto principal:
Neoplasias Esofágicas
/
Esofagectomía
/
Terapia Neoadyuvante
/
Quimioradioterapia
/
Carcinoma de Células Escamosas de Esófago
Límite:
Humans
Idioma:
Zh
Revista:
Chinese Journal of Gastrointestinal Surgery
Año:
2023
Tipo del documento:
Article